Body mass index and mortality rate among Hispanic adults: a pooled analysis of multiple epidemiologic data sets.

Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD 21224, USA.
International journal of obesity (2005) (Impact Factor: 5.22). 10/2011; 36(8):1121-6. DOI: 10.1038/ijo.2011.194
Source: PubMed

ABSTRACT To evaluate the association between body mass index (BMI, kg m⁻²) and mortality rate among Hispanic adults.
Analysis of five data sets (total N=16,798) identified after searching for publicly available, prospective cohort data sets containing relevant information for at least 500 Hispanic respondents (≥18 years at baseline), at least 5 years of mortality follow-up, and measured height and weight. Data sets included the third National Health and Nutrition Examination Survey, the Puerto Rico Heart Health Program (PRHHP), the Hispanic Established Population for Epidemiologic Studies of the Elderly (HEPESE), the San Antonio Heart Study (SAHS) and the Sacramento Area Latino Study on Aging.
Cox proportional hazards regression models, adjusting for sex and smoking, were fit within three attained-age strata (18 to younger than 60 years, 60 to younger than 70 years, and 70 years and older). We found that underweight was associated with elevated mortality rate for all age groups in the PRHHP (hazard ratios [HRs]=1.38-1.60) and the SAHS (HRs=1.88-2.51). Overweight (HRs=0.38 and 0.84) and obesity grade 2-3 (HRs=0.75 and 0.60) associated with reduced mortality rate in the HEPESE dataset for those in the 60 to younger than 70 years, and 70 years and older attained-age strata. Weighted estimates combining the HRs across the data sets revealed a similar pattern.
Among Hispanic adults, there was no clear evidence that overweight and obesity associate with elevated mortality rate.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Objectives. We examined the association of body mass index with all-cause and cardiovascular disease (CVD)-specific mortality risks among US adults and calculated the rate advancement period by which death is advanced among the exposed groups. Methods. We used data from the Third National Health and Nutrition Examination Survey (1988-1994) linked to the National Death Index mortality file with follow-up to 2006 (n = 16 868). We used Cox proportional hazards regression to estimate the rate of dying and rate advancement period for all-cause and CVD-specific mortality for overweight and obese adults relative to their normal-weight counterparts. Results. Compared with normal-weight adults, obese adults had at least 20% significantly higher rate of dying of all-cause or CVD. These rates advanced death by 3.7 years (grades II and III obesity) for all-cause mortality and between 1.6 (grade I obesity) and 5.0 years (grade III obesity) for CVD-specific mortality. The burden of obesity was greatest among adults aged 45 to 64 years for all-cause and CVD-specific mortality and among women for all-cause mortality. Conclusions. These findings highlight the impact of the obesity epidemic on mortality risk and premature deaths among US adults. (Am J Public Health. Published online ahead of print January 16, 2014: e1-e8. doi:10.2105/AJPH.2013.301597).
    American Journal of Public Health 01/2014; · 3.93 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Objective It is debatable if the strength of obesity–mortality association depends on age. The objective of this study was to investigate the influence of age on the obesity–mortality association in men and women, and to assess if adjusting for major confounding factors altered the age-dependent trend of the obesity–mortality association. Design and methods Articles were identified by searches of PubMed through 15 August 2013. Twenty studies which reported two or more age-specific effect estimates were identified. A random-effect approach was applied to estimate pooled effect sizes for different age groups. Results There was a significant heterogeneity among studies within each age group in the effect estimates for the association between obesity and mortality. The pooled hazard ratio estimates decreased with increasing age from 1.59 (95% confidence interval, 1.46–1.72) for men and 1.60 (1.49–1.72) for women under 35 years to 1.11 (1.08–1.15) for men and 1.11 (1.09–1.14) for women 75 years or older. On average, the effect estimate was decreased by about 10% with every 10 years increase in age. Conclusions Adjusting for known confounding factors of smoking, pre-existing illness, hypertension and diabetes has little impact on the age-dependent decline trend of the obesity–mortality association. Therefore, the strength of the association between obesity and mortality weakens with increasing age.
    Obesity Research & Clinical Practice 03/2014; 9(1). · 0.70 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this review, we discuss strengths and limitations of a recent rigorous systematic review and meta-analysis of the literature on associations of all-cause mortality with overweight and obesity. A perspective on its meaning and potential implications are provided. To move this field forward, we suggest modeling BMI as a continuous variable, switching to modeling longevity instead of mortality, and generating large publicly available datasets in broad and diverse populations for discerning the extent to which the BMI-mortality relationship differs between groups and over time. Randomized studies of obesity-related interventions that provide assessments of their actual effects on lifespan or mortality would have great value for helping to establish valid clinical and public health recommendations around weight loss and mortality.
    Molecular metabolism. 04/2013; 2(2):65-68.

Full-text (2 Sources)

Available from
Jun 1, 2014